Video

CASE STUDY: Transforming surgical waitlist into a ‘preparation list’

By Bench Side Story — 3 weeks ago

The DIAMONDS initiative aims to transform the surgical waitlist into a “preparation list,” enabling healthcare professionals to optimise patient care in the months leading up to elective surgery starting at pre-admission phase.

Patients are will be able to complete pre-admission forms online, receive timely updates, and access educational resources to ensure thorough preparation. This will allow staff to spend more time with patients.

Post Views: 135

Systems genetics to determine risk of developing diabetes complications

By Bench Side Story — 1 month ago

Professor Morahan invented the term “Systems Genetics” for the science field that examines how genetic variants can affect whole networks of genes and whole systems; there are now several laboratories and institutes of systems genetics around the world. He also developed the next-generation genetic resource, The Gene Mine, the most powerful of its type in the world, used globally in rapid mapping and identification of genes. Collaborators nationally and internationally have tested The Gene Mine for traits and diseases in which they specialise.

Post Views: 163

Pancreatic and lung cancers driven by mutations in the cancer gene KRAS

By Bench Side Story — 2 months ago

Dr Mara Zeissig is a recently appointed Lab Head within the Tumour Inflammation and Immunotherapy Program at the South Australian immunoGENomics Cancer Institute (SAiGENCI).
Her research focuses on studying immune evasion mechanisms in lung and pancreatic cancers to identify novel ways to increase response to immunotherapy. Her expertise is in genetically engineered mouse models of lung cancer, CRISPR-Cas9 screening technologies and T cell based immunotherapies (e.g Checkpoint inhibitors).

Post Views: 222

Biopsychosocial approaches to obsessive-compulsive, body image and eating disorders

By Bench Side Story — 2 months ago

Dr Nicola Acevedo is a Neuroscientist and Research Fellow with extensive expertise in developing novel therapeutics for neurological and psychiatric disorders, contributing to more than ten clinical trials. She specialises in brain stimulation and psychedelic treatments for obsessive-compulsive disorder (OCD) and related conditions, with a strong commitment to advancing personalised, evidence-based neurobiological therapies for severe psychiatric illness. Her approach integrates biopsychosocial and person-centred principles to improve treatment access and mental health outcomes.

Post Views: 250

Nanoparticles & microparticles to combat antimicrobial resistance

By Bench Side Story — 2 months ago

Dr Anjana Jayasree is an emerging research leader in biomaterials, tissue engineering and nanotechnology, recognised internationally for her innovative work on antimicrobial nanoparticles and regenerative therapies. A Postdoctoral Research Fellow at The University of Queensland, she operates at the intersection of materials science, drug delivery and cellular biology, developing advanced metallic-based nanotechnologies to improve both human and animal health outcomes. Her expertise spans nanoparticle synthesis, cell–material interactions, and the design of sophisticated in vitro models to investigate soft-tissue integration, osseointegration, angiogenesis and biofilm formation.

Post Views: 213

Electrical stimulation on organic conductors

By Bench Side Story — 2 months ago

Professor Gordon Wallace AO is the Founder and Director of the Intelligent Polymer Research Institute (IPRI) at the University of Wollongong and Founding Director of the Australian National Fabrication Facility (ANFF) Materials Node. He was previously the Executive Director of the ARC Centre of Excellence for Electromaterials Science (ACES).

Post Views: 175

Neuroscience, neuropharmacology and exercise science

By Bench Side Story — 2 months ago

Dr Jacob Thorstensen is an early-career Assistant Professor in Neuroscience and Physiology in the Faculty of Health Sciences & Medicine at Bond University. He is also an honorary research fellow in The School of Biomedical Sciences at The University of Queensland. His work has unveiled several new neuroscientific mechanisms which have future applications for movement disorders.

Post Views: 173

New treatments for patients with mental illness

By Bench Side Story — 2 months ago

Associate Professor Bernadette Fitzgibbon is a neuroscientist with several decades of experience in researching, developing, and translating novel therapies for mental health and chronic pain conditions. This includes the application and optimisation of brain stimulation and psychedelic therapies, overseeing large multi-site intervention trials, both within Australia and abroad. Through her work, she has developed meaningful collaborations with consumers, volunteers, policy makers, and services providers, ensuring that the outcomes of her work contribute towards real-world clinical impact.

Post Views: 149

Medically Complex Pregnancies

By Bench Side Story — 2 months ago

A/Prof Shelley Wilkinson is an Advanced Accredited Practising Dietitian, Fellow of Dietitians Australia, and a leading Australian researcher in maternal health and implementation science.

She has over 30 years of experience in the field and holds a PhD in Psychology. Her passion is in health service redesign through co-creation and combining the ‘know-what’ of nutrition with the ‘know-how’ of innovative behaviour change techniques.

Post Views: 210

Lymphoma, Myeloma and Genomics

By Bench Side Story — 2 months ago

Professor Dipti Talaulikar is a clinical and laboratory haematologist with expertise in genomics, working at Canberra Health Services, and Professor at ANU. She has a clinical and research interest in lymphoma, myeloma and genomics, and has authored close to 100 peer reviewed papers, including several clinical guidelines that have had a significant impact on clinical practice.

1
2
3
…
16
Next ›

Scroll to top